FindTrial
Sign In

Investigation on the positive rate of insulin antibody in patients with type 2 diabetes treated with insulin

Investigation on the positive rate of insulin antibody in diabetes patients treated with insulin in some areas of Xiangshan

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048099
Enrollment
Unknown
Registered
2021-06-30
Start date
2020-01-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Case series:Nil

Sponsors

Zhejiang xiangshan hospital of traditional Chinese medicine and health group
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients with type 2 diabetes who were treated with insulin were registered by our medical and health group; 2. Voluntary participation in the study.

Exclusion criteria

Exclusion criteria: Patients with acute complications of diabetes mellitus (diabetic ketoacidosis, hyperosmotic hyperglycemia, etc.), various emergency situations, pregnancy, acute and chronic infection, severe cardiopulmonary insufficiency, liver and kidney insufficiency, severe anemia, tumor, hyperthyroidism, rheumatism and immune system diseases, depression, mania and other mental diseases, no autonomy and other effects Patients with diabetes mellitus

Design outcomes

Primary

MeasureTime frame
Insulin antibody;Insulin antibody;—

Countries

China

Contacts

Public ContactYao Dan

Zhejiang xiangshan hospital of traditional Chinese medicine and health group

3299048@qq.com+86 13777191528

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026